Trial Profile
A Comparison of Drug Eluting and Bare Metal Stents with Bivalirudin during PCI or Bivalirudin for 4 hours in Acute Coronary Syndromes. The Eindhoven Reperfusion Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Jun 2011
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Everolimus (Primary)
- Indications Acute coronary syndromes; Coronary artery disease; Coronary artery restenosis; Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms DEBATER-2
- 25 Jun 2011 New trial record